These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30181807)

  • 41. Prognostic value of sentinel lymph node biopsy compared with that of Breslow thickness: implications for informed consent in patients with invasive melanoma.
    Freeman SR; Gibbs BB; Brodland DG; Zitelli JA
    Dermatol Surg; 2013 Dec; 39(12):1800-12. PubMed ID: 24299573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome.
    Journe F; Id Boufker H; Van Kempen L; Galibert MD; Wiedig M; Salès F; Theunis A; Nonclercq D; Frau A; Laurent G; Awada A; Ghanem G
    Br J Cancer; 2011 Nov; 105(11):1726-32. PubMed ID: 22045183
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vertical Growth Phase as a Prognostic Factor for Sentinel Lymph Node Positivity in Thin Melanomas: A Systematic Review and Meta-Analysis.
    Appleton SE; Fadel Z; Williams JS; Bezuhly M
    Plast Reconstr Surg; 2018 Jun; 141(6):1529-1540. PubMed ID: 29579032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.
    Wong SL; Faries MB; Kennedy EB; Agarwala SS; Akhurst TJ; Ariyan C; Balch CM; Berman BS; Cochran A; Delman KA; Gorman M; Kirkwood JM; Moncrieff MD; Zager JS; Lyman GH
    J Clin Oncol; 2018 Feb; 36(4):399-413. PubMed ID: 29232171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disease progression in patients with thin cutaneous melanomas (tumour thickness < or = 0.75 mm): clinical and epidemiological data from the Tumour Center Munich 1977-98.
    Schmid-Wendtner MH; Baumert J; Eberle J; Plewig G; Volkenandt M; Sander CA
    Br J Dermatol; 2003 Oct; 149(4):788-93. PubMed ID: 14616371
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic Significance of Periadnexal Extension in Cutaneous Melanoma and its Implications for Pathologic Reporting and Staging.
    Dodds TJ; Lo S; Jackett L; Nieweg O; Thompson JF; Scolyer RA
    Am J Surg Pathol; 2018 Mar; 42(3):359-366. PubMed ID: 29240580
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thin Melanoma: A Generic Term Including Four Histological Subtypes of Cutaneous Melanoma.
    Roncati L; Pusiol T; Piscioli F
    Acta Dermatovenerol Croat; 2016 Dec; 24(4):169-174. PubMed ID: 28128089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Time to Procedure, Nuclear Imaging and Clinicopathological Characteristics as Predictive Factors for Sentinel Lymph Node Metastasis in Cutaneous Melanoma: A Single-Center Analysis.
    Jaukovic L; Rajović M; Kandolf Sekulovic L; Radulovic M; Stepic N; Mijuskovic Z; Petrov N; Ajdinovic B
    Ann Plast Surg; 2018 Jul; 81(1):80-86. PubMed ID: 29762449
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sentinel lymph node status affects long-term survival in patients with intermediate-thickness melanoma.
    G Lben K; Berberoğlu U; Altınyollar H; Kınaş V; Turanlı S
    J Cancer Res Ther; 2016; 12(2):840-4. PubMed ID: 27461661
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic factors for Taiwanese patients with cutaneous melanoma undergoing sentinel lymph node biopsy.
    Wu CE; Hsieh CH; Chang CJ; Yeh JT; Kuo TT; Yang CH; Lo YF; Lin KJ; Lin YC; Chang JW
    J Formos Med Assoc; 2015 May; 114(5):415-21. PubMed ID: 23969039
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
    Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
    J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
    Fairbairn NG; Orfaniotis G; Butterworth M
    J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anthropometric factors and Breslow thickness: prospective data on 2570 cases of cutaneous melanoma in the population-based Janus Cohort.
    Stenehjem JS; Veierød MB; Nilsen LT; Ghiasvand R; Johnsen B; Grimsrud TK; Babigumira R; Støer NC; Rees JR; Robsahm TE
    Br J Dermatol; 2018 Sep; 179(3):632-641. PubMed ID: 29858512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thin melanomas: predictive lethal characteristics from a 30-year clinical experience.
    Kalady MF; White RR; Johnson JL; Tyler DS; Seigler HF
    Ann Surg; 2003 Oct; 238(4):528-35; discussion 535-7. PubMed ID: 14530724
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma.
    Stiegel E; Xiong D; Ya J; Funchain P; Isakov R; Gastman B; Vij A
    J Am Acad Dermatol; 2018 May; 78(5):942-948. PubMed ID: 29408526
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II).
    Balch CM; Soong SJ; Murad TM; Ingalls AL; Maddox WA
    Ann Surg; 1981 Mar; 193(3):377-88. PubMed ID: 7212800
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic factors for melanoma in children and adolescents: a clinicopathologic, single-center study of 137 Patients.
    Paradela S; Fonseca E; Pita-Fernández S; Kantrow SM; Diwan AH; Herzog C; Prieto VG
    Cancer; 2010 Sep; 116(18):4334-44. PubMed ID: 20549825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Angiotropism in primary cutaneous melanoma with brain metastasis: a study of 20 cases.
    Hung T; Morin J; Munday WR; Mackenzie IR; Lugassy C; Barnhill RL
    Am J Dermatopathol; 2013 Aug; 35(6):650-4. PubMed ID: 23392133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.